Codexis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Codexis and other ETFs, options, and stocks.About CDXS
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments.
CEOAlison Moore
CEOAlison Moore
Employees188
Employees188
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2002
Founded2002
Employees188
Employees188
CDXS Key Statistics
Market cap158.97M
Market cap158.97M
Price-Earnings ratio-2.36
Price-Earnings ratio-2.36
Dividend yield—
Dividend yield—
Average volume1.01M
Average volume1.01M
High today$1.78
High today$1.78
Low today$1.67
Low today$1.67
Open price$1.72
Open price$1.72
Volume701.13K
Volume701.13K
52 Week high$6.08
52 Week high$6.08
52 Week low$1.52
52 Week low$1.52
Stock Snapshot
With a market cap of 158.97M, Codexis(CDXS) trades at $1.75. The stock has a price-to-earnings ratio of -2.36.
As of 2025-12-04, Codexis(CDXS) stock has fluctuated between $1.67 and $1.78. The current price stands at $1.75, placing the stock +5.1% above today's low and -1.4% off the high.
Codexis(CDXS) shares are trading with a volume of 701.13K, against a daily average of 1.01M.
During the past year, Codexis(CDXS) stock moved between $1.52 at its lowest and $6.08 at its peak.
During the past year, Codexis(CDXS) stock moved between $1.52 at its lowest and $6.08 at its peak.
Analyst ratings
71%
of 7 ratingsBuy
71.4%
Hold
28.6%
Sell
0%
People also own
Based on the portfolios of people who own CDXS. This list is generated using Robinhood data, and it’s not a recommendation.